NASDAQ:ANPC

AnPac Bio-Medical Science Stock Forecast, Price & News

$4.03
+0.08 (+2.03 %)
(As of 08/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.92
$4.11
50-Day Range
$3.77
$4.88
52-Week Range
$3.15
$12.09
Volume42,854 shs
Average Volume858,330 shs
Market Capitalization$48.59 million
P/E RatioN/A
Dividend YieldN/A
Beta1.91
30 days | 90 days | 365 days | Advanced Chart
Receive ANPC News and Ratings via Email

Sign-up to receive the latest news and ratings for AnPac Bio-Medical Science and its competitors with MarketBeat's FREE daily newsletter.


AnPac Bio-Medical Science logo

About AnPac Bio-Medical Science

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China. It offers cancer differentiation analysis devices and physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.13 out of 5 stars

Medical Sector

1143rd out of 1,309 stocks

Medical Laboratories Industry

24th out of 29 stocks

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











AnPac Bio-Medical Science (NASDAQ:ANPC) Frequently Asked Questions

What stocks does MarketBeat like better than AnPac Bio-Medical Science?

Wall Street analysts have given AnPac Bio-Medical Science a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AnPac Bio-Medical Science wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting AnPac Bio-Medical Science?

AnPac Bio-Medical Science saw a drop in short interest in July. As of July 15th, there was short interest totaling 97,000 shares, a drop of 71.1% from the June 30th total of 335,400 shares. Based on an average trading volume of 1,020,000 shares, the short-interest ratio is currently 0.1 days.
View AnPac Bio-Medical Science's Short Interest
.

How were AnPac Bio-Medical Science's earnings last quarter?

AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) issued its quarterly earnings data on Thursday, May, 27th. The company reported ($0.37) EPS for the quarter. The company earned $0.33 million during the quarter.
View AnPac Bio-Medical Science's earnings history
.

How has AnPac Bio-Medical Science's stock been impacted by Coronavirus (COVID-19)?

AnPac Bio-Medical Science's stock was trading at $8.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ANPC shares have decreased by 52.6% and is now trading at $4.03.
View which stocks have been most impacted by COVID-19
.

Who are AnPac Bio-Medical Science's key executives?

AnPac Bio-Medical Science's management team includes the following people:
  • Dr. Chris Chang Yu, Co-Founder, Chairman & CEO (Age 63)
  • Dr. He Yu, Co-Founder & Chief Medical Officer (Age 63)
  • Mr. Jinqiu Tang, Chief Financial Officer (Age 38)
  • Mr. Weidong Dai, China Pres (Age 60)

Who are some of AnPac Bio-Medical Science's key competitors?

What other stocks do shareholders of AnPac Bio-Medical Science own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AnPac Bio-Medical Science investors own include Applied Genetic Technologies (AGTC), Aurora Cannabis (ACB), Adobe (ADBE), Advaxis (ADXS), Aptose Biosciences (APTO), Arcturus Therapeutics (ARCT), Ardelyx (ARDX), Ascendis Pharma A/S (ASND), Athenex (ATNX) and Aurinia Pharmaceuticals (AUPH).

When did AnPac Bio-Medical Science IPO?

(ANPC) raised $22 million in an initial public offering on the week of January 13th 2020. The company issued 1,700,000 shares at $12.00-$14.00 per share. WestPark Capital and Univest Securities acted as the underwriters for the IPO.

What is AnPac Bio-Medical Science's stock symbol?

AnPac Bio-Medical Science trades on the NASDAQ under the ticker symbol "ANPC."

How do I buy shares of AnPac Bio-Medical Science?

Shares of ANPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AnPac Bio-Medical Science's stock price today?

One share of ANPC stock can currently be purchased for approximately $4.03.

How much money does AnPac Bio-Medical Science make?

AnPac Bio-Medical Science has a market capitalization of $48.59 million and generates $3.14 million in revenue each year. The company earns $-12,330,000.00 in net income (profit) each year or ($1.10) on an earnings per share basis.

How many employees does AnPac Bio-Medical Science have?

AnPac Bio-Medical Science employs 147,000 workers across the globe.

What is AnPac Bio-Medical Science's official website?

The official website for AnPac Bio-Medical Science is www.anpacbio.com.

Where are AnPac Bio-Medical Science's headquarters?

AnPac Bio-Medical Science is headquartered at 801 BIXING STREET BIHU COUNTY ZHEJIANG PROVINCE, LISHUI F4, 323006.

How can I contact AnPac Bio-Medical Science?

AnPac Bio-Medical Science's mailing address is 801 BIXING STREET BIHU COUNTY ZHEJIANG PROVINCE, LISHUI F4, 323006. The company can be reached via phone at 86-578-2051-6666 or via email at [email protected]


This page was last updated on 8/4/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.